Comera Life Sciences Holdings
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Comera Life Sciences Holdings generated cash of -$9,771,770, which is less than the previous year. Cash used in financing activities reached the amount of $5,242,469 last year. Net change in cash is therefore -$4,557,908.
Cash Flow
| 2020 | -1.80M | -12.36K | 1.55M |
|---|---|---|---|
| 2021 | -3.75M | -142.01K | 10.27M |
| 2022 | -9.77M | -28.60K | 5.24M |
CMRA Cash Flow Statement (2020 – 2022)
| 2022 | 2021 | 2020 | |
|---|---|---|---|
Cash at beginning of period | 6.56M | 180.42K | 444.56K |
Operating activities | |||
Net income | -18.00M | -5.45M | -2.12M |
| Adjustments to reconcile net income to cash generated by operating activities: | |||
Depreciation and amortization | 93.94K | 86.13K | 89.74K |
Stock-based compensation expense | 375.79K | 1.11M | 101.04K |
| Deferred income tax benefit | 375.79K | 1.11M | 101.04K |
| Changes in operating assets and liabilities: | |||
Accounts receivable, net | -34.32K | 109.86K | -113.06K |
Inventories | 0 | 173.96K | 76.24K |
Accounts payable | 862.92K | 319.32K | 20.98K |
Cash generated by operating activities | -9.77M | -3.75M | -1.80M |
Investing activities | |||
Purchases Of Investments | 0 | 0 | 0 |
Investments In Property Plant And Equipment | -28.60K | -142.01K | -12.36K |
Acquisitions Net | 0 | 0 | 0 |
Cash generated by investing activities | -28.60K | -142.01K | -12.36K |
Financing activities | |||
Common Stock Issued | 829.46K | 0 | 1.39M |
Payments for dividends | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 |
Repayments of term debt | 0 | -750K | -160.58K |
Cash used in financing activities | 5.24M | 10.27M | 1.55M |
Net Change In Cash | -4.55M | 6.37M | -264.14K |
Cash at end of period | 2.00M | 6.56M | 180.42K |
| Data source |